Hotspots and frontiers in pulmonary arterial hypertension research: a bibliometric and visualization analysis from 2011 to 2020
ABSTRACTPulmonary arterial hypertension (PAH) is a group of devastating and progressive disorders, resulting in relentless increases in pulmonary vascular resistance. The number of studies related to PAH has been increasing in recent years. Our study aims to illustrate trends in PAH research over th...
Main Authors: | Zhen He, Lei Dai, Yuyue Zuo, Yu Chen, Hongjie Wang, Hesong Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-06-01
|
Series: | Bioengineered |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21655979.2022.2100064 |
Similar Items
-
Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration
by: Jenna M. Faircloth, et al.
Published: (2023-03-01) -
Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration
by: Jenna M. Faircloth, et al.
Published: (2023-08-01) -
Selexipag in pregnancy and pulmonary arterial hypertension
by: Sweta Mohanty, et al.
Published: (2023-01-01) -
Hemodynamic assessment of transitioning from parenteral prostacyclin to selexipag in pediatric pulmonary hypertension
by: Elizabeth Colglazier, et al.
Published: (2022-10-01) -
Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
by: Julia McSweeney, et al.
Published: (2023-04-01)